{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT02734277",
            "orgStudyIdInfo": {
                "id": "DAIT ITN066AI"
            },
            "secondaryIdInfos": [
                {
                    "id": "NIAID CRMS ID#: 20722",
                    "type": "OTHER",
                    "domain": "DAIT NIAID"
                }
            ],
            "organization": {
                "fullName": "National Institute of Allergy and Infectious Diseases (NIAID)",
                "class": "NIH"
            },
            "briefTitle": "Type 1 Diabetes Extension Study",
            "officialTitle": "Type 1 Diabetes Extension Study",
            "acronym": "T1DES",
            "therapeuticArea": [
                "Endocrinology",
                "Other"
            ],
            "study": "type-diabetes-extension-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2016-08-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2016-04-06",
            "studyFirstSubmitQcDate": "2016-04-06",
            "studyFirstPostDateStruct": {
                "date": "2016-04-12",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2024-04-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "National Institute of Allergy and Infectious Diseases (NIAID)",
                "class": "NIH"
            },
            "collaborators": [
                {
                    "name": "Immune Tolerance Network (ITN)",
                    "class": "NETWORK"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true
        },
        "descriptionModule": {
            "briefSummary": "This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodulatory agents (T1DM, T1D).\n\nThis observational study will:\n\n* follow participants to determine how long they continue to produce insulin, and\n* will also assess how changes in the immune system over time relate to the ability to produce insulin.\n\nThis information could help design better therapies for type 1 diabetes in the future.",
            "detailedDescription": "Depending upon a participant's level of insulin production, participation may be as short as one return visit or a maximum of five years. Evaluation visits will include:\n\n* Overall health assessments\n* Blood and urine collections\n* Mixed meal tolerance test (MMTTs) for certain participants, per protocol."
        },
        "conditionsModule": {
            "conditions": [
                "Type 1 Diabetes Mellitus",
                "T1DM",
                "T1D"
            ],
            "keywords": [
                "Insulin",
                "Glucose Intolerance"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITHOUT_DNA",
                "description": "* Blood or urine tests as needed to follow-up on potential long term safety concerns with a particular therapeutic agent\n* Blood and urine samples for additional studies related to your diabetes"
            },
            "enrollmentInfo": {
                "count": 111,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Group 1: Detectable C-peptide by MMTT",
                    "description": "Participants with detectable C-peptide at their:\n\n* Last Immune Tolerance Network (ITN) T1DM week 104 study visit,\n* Last AbATE (NCT00129259) follow-up visit, or\n* Last ITN066AI T1DES visit\n\nDetectable C-peptide is defined as a value above the lower limit of detection."
                },
                {
                    "label": "Group 2:Undetectable C-peptide by MMTT",
                    "description": "Participants without detectable C-peptide at their:\n\n* Last ITN T1DM week 104 study visit,\n* Last AbATE follow-up visit, or last\n* ITN066AI T1DES visit\n\nUndetectable C-peptide is defined as a value below the lower limit of detection."
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in Beta Cell Function by MMTT-Stimulated Mean C-peptide Area Under the Curve (AUC)",
                    "description": "Evaluation of changes in beta cell function over time will be measured by mixed-meal tolerance test (MMTT) -Stimulated mean C-Peptide area under the curve (AUC).\n\nC-peptide is released by the pancreas into the bloodstream in equal amounts to insulin and reflects how much insulin pancreatic beta cells are making. The standardized MMTT evaluates whether beta cells are producing endogenous insulin.\n\nDetectable C-peptide is defined as any value during a MMTT of \u22650.15 ng/mL.",
                    "timeFrame": "Baseline (Visit 0) to Month 60 (Year 5)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in Insulin Use in Units per Kilogram Body Weight Per Day",
                    "description": "The need to use exogenous insulin is an indication that the body is not producing enough endogenous insulin. Higher amounts of insulin use indicate higher disease activity.",
                    "timeFrame": "Baseline (Visit 0) to Month 60 (Year 5)"
                },
                {
                    "measure": "Change in HbA1C",
                    "description": "Glycosylated hemoglobin (HbA1c) is a measure of the average plasma concentration of blood sugar (glucose) over the previous three months and measures the level of optimal management of underlying disease.",
                    "timeFrame": "Baseline (Visit 0) to Month 60 (Year 5)"
                },
                {
                    "measure": "Count of Participant-Reported Major Hypoglycemic Events",
                    "description": "Major hypoglycemic events are defined as a glucose concentration \\<55 mg/dL (grades 2-5, NCI-CTCAE version 4.03), or clinically: involving seizure(s) or involving loss of consciousness (coma), or requiring assistance from another individual in order to recover.",
                    "timeFrame": "Baseline (Visit 0) to Month 60 (Year 5)"
                },
                {
                    "measure": "Time to Undetectable C-Peptide",
                    "description": "To assess the longevity of beta cell function, time to undetectable C-peptide will be evaluated using Kaplan-Meier survival estimates.",
                    "timeFrame": "Baseline (Visit 0) to Month 60 (Year 5)"
                },
                {
                    "measure": "Frequency of Grade 3 or Higher Adverse Events (AEs) of Interest",
                    "description": "Events of interest include but are not limited to:\n\n* Opportunistic and serious infections\n* Malignancy\n* Cardiovascular disease\n* Development of autoimmune disease(s)\n* Hypersensitivity reactions to unrelated allergens\n\nReference for Grade 3 or higher AEs: National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE), Version 4.03 (June 14, 2010).",
                    "timeFrame": "Baseline (Visit 0) to Month 60 (Year 5)"
                },
                {
                    "measure": "Severity of Grade 3 or Higher Adverse Events (AEs) of Interest",
                    "description": "Events of interest include but are not limited to:\n\n* Opportunistic and serious infections\n* Malignancy\n* Cardiovascular disease\n* Development of autoimmune disease(s)\n* Hypersensitivity reactions to unrelated allergens\n\nReference for Grade 3 or higher AEs: National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE), Version 4.03 (June 14, 2010).",
                    "timeFrame": "Baseline (Visit 0) to Month 60 (Year 5)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Prior participant in an Immune Tolerance Network (ITN) executive committee approved T1DM study.\n* Ability to sign informed consent/assent (as applicable for children).\n\nExclusion Criteria:\n\n* Any medical condition that in the opinion of the principal investigator would interfere with safe completion of the trial; or\n* Inability to comply with the study visit schedule and required assessments.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "8 Years",
            "maximumAge": "35 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ],
            "studyPopulation": "Former participants in Immune Tolerance Network (ITN) new-onset Type 1 Diabetes Mellitus (T1DM) studies with immunomodulatory agents as the intervention.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "overallOfficials": [
                {
                    "name": "Linda A. DiMeglio, MD, MPH,MA",
                    "affiliation": "Riley Hospital for Children at Indiana University Health",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "UCSF School of Medicine",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94143",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rebecca Wesch",
                            "role": "CONTACT",
                            "phone": "415-476-5984",
                            "email": "rebecca.wesch@ucsf.edu"
                        },
                        {
                            "name": "Stephen Gitelman, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Stanford University",
                    "status": "RECRUITING",
                    "city": "Stanford",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Trudy Esrey",
                            "role": "CONTACT",
                            "phone": "650-498-4450",
                            "email": "tesrey@stanford.edu"
                        },
                        {
                            "name": "Darrell Wilson, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.42411,
                        "lon": -122.16608
                    }
                },
                {
                    "facility": "University of Colorado School of Medicine: Barbara Davis Center for Diabetes",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mara Kinney",
                            "role": "CONTACT",
                            "phone": "303-724-8272",
                            "email": "MARA.KINNEY@ucdenver.edu"
                        },
                        {
                            "name": "Peter Gottlieb, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Yale University",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06519",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Linda Ryall",
                            "role": "CONTACT",
                            "phone": "203-737-4510",
                            "email": "linda.ryall@yale.edu"
                        },
                        {
                            "name": "Mikhail Smolgovsky",
                            "role": "CONTACT",
                            "phone": "203-785-6248",
                            "email": "mikhail.smolgovsky@yale.edu"
                        },
                        {
                            "name": "Kevan Herold, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Emory University",
                    "status": "WITHDRAWN",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Indiana University Riley Hospital for Children",
                    "status": "RECRUITING",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ellie Ryan",
                            "role": "CONTACT",
                            "phone": "317-278-7037",
                            "email": "elmryan@iu.edu"
                        },
                        {
                            "name": "Maria Spall",
                            "role": "CONTACT",
                            "phone": "317-278-7034",
                            "email": "malnicho@iu.edu"
                        },
                        {
                            "name": "Linda DiMeglio, MD, MPH",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                },
                {
                    "facility": "University of Iowa Health Care Division of Pediatric Endocrinology",
                    "status": "RECRUITING",
                    "city": "Iowa City",
                    "state": "Iowa",
                    "zip": "52242",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Joanne Cabbage",
                            "role": "CONTACT",
                            "phone": "319-356-4035",
                            "email": "joanne-cabbage@uiowa.edu"
                        },
                        {
                            "name": "Michael Tansey, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.66113,
                        "lon": -91.53017
                    }
                },
                {
                    "facility": "Joslin Diabetes Center",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "888-813-8669",
                            "email": "T1DTrials@joslin.harvard.edu"
                        },
                        {
                            "name": "Jason Gaglia, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "University of Minnesota",
                    "status": "RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55454",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Anne Street",
                            "role": "CONTACT",
                            "phone": "612-625-9709",
                            "email": "stree065@umn.edu"
                        },
                        {
                            "name": "Antoinette Moran, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                },
                {
                    "facility": "Children's Mercy Hospital",
                    "status": "RECRUITING",
                    "city": "Kansas City",
                    "state": "Missouri",
                    "zip": "64108",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Marissa Beidelschies",
                            "role": "CONTACT",
                            "phone": "816-760-5918",
                            "email": "mkbeidelschies@cmh.edu"
                        },
                        {
                            "name": "Jennifer Dolan",
                            "role": "CONTACT",
                            "phone": "(816) 760-8876",
                            "email": "jldolan@cmh.edu"
                        },
                        {
                            "name": "Wayne Moore, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.09973,
                        "lon": -94.57857
                    }
                },
                {
                    "facility": "Sanford Research",
                    "status": "RECRUITING",
                    "city": "Sioux Falls",
                    "state": "South Dakota",
                    "zip": "57104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sarah Hedeen",
                            "role": "CONTACT",
                            "email": "Sarah.Hedeen@SanfordHealth.org"
                        },
                        {
                            "name": "Kurt Griffin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.54997,
                        "lon": -96.70033
                    }
                },
                {
                    "facility": "Benaroya Research Institute",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98101",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Katie Bennett",
                            "role": "CONTACT",
                            "phone": "206-341-8945",
                            "email": "kbennett@benaroyaresearch.org"
                        },
                        {
                            "name": "Sandra Lord, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "23835333",
                    "type": "BACKGROUND",
                    "citation": "Herold KC, Gitelman SE, Ehlers MR, Gottlieb PA, Greenbaum CJ, Hagopian W, Boyle KD, Keyes-Elstein L, Aggarwal S, Phippard D, Sayre PH, McNamara J, Bluestone JA; AbATE Study Team. Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders. Diabetes. 2013 Nov;62(11):3766-74. doi: 10.2337/db13-0345. Epub 2013 Jul 8."
                },
                {
                    "pmid": "26193635",
                    "type": "BACKGROUND",
                    "citation": "Rigby MR, Harris KM, Pinckney A, DiMeglio LA, Rendell MS, Felner EI, Dostou JM, Gitelman SE, Griffin KJ, Tsalikian E, Gottlieb PA, Greenbaum CJ, Sherry NA, Moore WV, Monzavi R, Willi SM, Raskin P, Keyes-Elstein L, Long SA, Kanaparthi S, Lim N, Phippard D, Soppe CL, Fitzgibbon ML, McNamara J, Nepom GT, Ehlers MR. Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients. J Clin Invest. 2015 Aug 3;125(8):3285-96. doi: 10.1172/JCI81722. Epub 2015 Jul 20."
                },
                {
                    "pmid": "24622414",
                    "type": "BACKGROUND",
                    "citation": "Rigby MR, DiMeglio LA, Rendell MS, Felner EI, Dostou JM, Gitelman SE, Patel CM, Griffin KJ, Tsalikian E, Gottlieb PA, Greenbaum CJ, Sherry NA, Moore WV, Monzavi R, Willi SM, Raskin P, Moran A, Russell WE, Pinckney A, Keyes-Elstein L, Howell M, Aggarwal S, Lim N, Phippard D, Nepom GT, McNamara J, Ehlers MR; T1DAL Study Team. Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Diabetes Endocrinol. 2013 Dec;1(4):284-94. doi: 10.1016/S2213-8587(13)70111-6. Epub 2013 Sep 23."
                }
            ],
            "seeAlsoLinks": [
                {
                    "label": "ITN T1D Extended Study (T1DES) website",
                    "url": "https://www.immunetolerance.org/studies/t1d-extended-study-t1des"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "The plan is to share data in: 1.)ImmPort, a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts that also provides data analysis tools that are available to researchers who register online and subsequently receive DAIT approval; and 2.)TrialShare, a clinical trials research portal developed by the Immune Tolerance Network that makes data from the consortium's clinical trials publicly available without charge.",
            "timeFrame": "After completion of the study.",
            "accessCriteria": "Will be available to the public.",
            "url": "http://www.immport.org/immport-open/public/home/home"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000003922",
                    "term": "Diabetes Mellitus, Type 1"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M20295",
                    "name": "Glucose Intolerance",
                    "relevance": "LOW"
                },
                {
                    "id": "M7117",
                    "name": "Diabetes Mellitus, Type 1",
                    "asFound": "Type 1 Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "asFound": "Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M10365",
                    "name": "Insulin",
                    "relevance": "LOW"
                },
                {
                    "id": "M173166",
                    "name": "Insulin, Globin Zinc",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}